Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Prime Medicine
PRME
$591M
| $173K | ﹤0.01% |
+14,091
| New | +$230K |
|
2527
Definitive Healthcare
DH
$67.9M
| $172K | ﹤0.01% |
+16,660
| New | +$196K |
|
|
VLD
2528
DELISTED
Velo3D, Inc.
VLD
| $172K | ﹤0.01% |
+2,165
| New | +$194K |
|
|
REVG
2529
DELISTED
REV Group
REVG
| $171K | ﹤0.01% |
+14,254
| New | +$178K |
|
2530
Pennant Group
PNTG
$1.33B
| $171K | ﹤0.01% |
+11,954
| New | +$150K |
|
2531
Vanda Pharmaceuticals
VNDA
$298M
| $169K | ﹤0.01% |
24,908
+13,762
| +123% | +$96.8K |
|
|
SFIX
2532
Stitch Fix
SFIX
$499M
| $168K | ﹤0.01% |
32,945
+20,705
| +169% | +$97K |
|
2533
TaskUs
TASK
$633M
| $167K | ﹤0.01% |
+11,582
| New | +$202K |
|
2534
Liquidity Services
LQDT
$1.31B
| $166K | ﹤0.01% |
+12,612
| New | +$172K |
|
|
TRTX
2535
TPG RE Finance Trust
TRTX
$614M
| $166K | ﹤0.01% |
22,833
+12,609
| +123% | +$100K |
|
2536
Babcock & Wilcox
BW
$1.37B
| $165K | ﹤0.01% |
27,312
+14,778
| +118% | +$91.1K |
|
2537
Aclaris Therapeutics
ACRS
$871M
| $165K | ﹤0.01% |
+20,389
| New | +$259K |
|
|
ROVR
2538
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $165K | ﹤0.01% |
36,447
+18,185
| +100% | +$73.3K |
|
2539
Westrock Coffee
WEST
$807M
| $163K | ﹤0.01% |
+13,350
| New | +$164K |
|
2540
Quanterix
QTRX
$124M
| $163K | ﹤0.01% |
+14,451
| New | +$185K |
|
|
ONL
2541
Orion Office REIT
ONL
$158M
| $162K | ﹤0.01% |
24,241
+13,379
| +123% | +$109K |
|
2542
Bridgewater Bancshares
BWB
$605M
| $161K | ﹤0.01% |
+14,838
| New | +$218K |
|
|
GLDD
2543
DELISTED
Great Lakes Dredge & Dock
GLDD
| $160K | ﹤0.01% |
29,599
+16,375
| +124% | +$98.1K |
|
|
PTVE
2544
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $157K | ﹤0.01% |
+19,707
| New | +$203K |
|
2545
Oscar Health
OSCR
$8.63B
| $154K | ﹤0.01% |
23,550
+10,585
| +82% | +$43.2K |
|
|
NUTX
2546
Nutex Health
NUTX
$1.14B
| $152K | ﹤0.01% |
1,009
+519
| +106% | +$105K |
|
|
SWI
2547
DELISTED
SolarWinds Corporation Common Stock
SWI
| $152K | ﹤0.01% |
+17,668
| New | +$164K |
|
2548
MaxCyte
MXCT
$133M
| $152K | ﹤0.01% |
30,707
+17,096
| +126% | +$84.2K |
|
2549
Blink Charging
BLNK
$85.5M
| $151K | ﹤0.01% |
+17,537
| New | +$185K |
|
2550
Invesco Mortgage Capital
IVR
$802M
| $151K | ﹤0.01% |
+13,644
| New | +$176K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.